These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 193991)

  • 21. A re-evaluated role for cyclic AMP in uterine relaxation. Differential effect of isoproterenol and forskolin.
    Do Khac L; Mokhtari A; Harbon S
    J Pharmacol Exp Ther; 1986 Oct; 239(1):236-42. PubMed ID: 3020232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of anti-Ig-activated serine protease in the generation of cytoplasmic factor(s) that are responsible for the transmission of Ig-receptor-mediated signals.
    Kishimoto T; Kikutani H; Nishizawa Y; Sakaguchi N; Yamamura Y
    J Immunol; 1979 Oct; 123(4):1504-10. PubMed ID: 314462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction.
    Wirth JJ; Kierszenbaum F
    J Immunol; 1982 Dec; 129(6):2759-62. PubMed ID: 6292299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cAMP and related compounds on newt epidermal cell migration both in vivo and in vitro.
    Dunlap MK; Donaldson DJ
    J Exp Zool; 1980 Apr; 212(1):13-9. PubMed ID: 6251154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of murine Peyer's patch immunoglobulin A response by enterotoxigenic Escherichia coli.
    Wess JA; Petro TM
    Infect Immun; 1987 May; 55(5):1085-9. PubMed ID: 3552986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein.
    Shirakawa F; Chedid M; Suttles J; Pollok BA; Mizel SB
    Mol Cell Biol; 1989 Mar; 9(3):959-64. PubMed ID: 2542770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Ishizaka K
    J Immunol; 1976 Feb; 116(2):534-41. PubMed ID: 175119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.
    Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
    J Immunol; 1991 Apr; 146(8):2712-8. PubMed ID: 1707917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells.
    Kishimoto T; Miyake T; Nishizawa Y; Watanabe T; Yamamura Y
    J Immunol; 1975 Nov; 115(5):1179-84. PubMed ID: 1080773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):585-91. PubMed ID: 1079034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic effect of cyclic amp on IgG production and on the changes of non-histone nuclear proteins induced with anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Nishizawa Y; Kikutani H; Yamamura Y
    J Immunol; 1977 Jun; 118(6):2027-33. PubMed ID: 193991
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic AMP-dependent protein kinase and its nuclear substrate proteins.
    Johnson EM
    Adv Cyclic Nucleotide Res; 1977; 8():267-309. PubMed ID: 200127
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.